-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
, Samutsakhon 74000 No. DOD43/2563 May 14, 2020 To: The President The Stock Exchange of Thailand (SET) Subject: Management’s Discussion and Analysis for the first Quarter of 2020 DOD Biotech Public Company
No: AH 03052021 May 17, 2021 Subject: Management Discussion & Analysis (MD&A) for the financial statements of the 1st quarter of fiscal year 2021 ended as of March 31, 2021 To: The President The Stock
No. ADD 12/2021 15 November 2021 Subject: Management discussion and analysis for the performance for the nine-month period ended 30 September 2021 To: President The Stock Exchange of Thailand AddTech
-1- AIT (VP-SEC) 025E/2023 August 10, 2023 Subject: Management's Discussion and Analysis of Operating Results for Q2-2023 To: The President of the Stock Exchange of Thailand Summary of Operations Q2
-1- AIT (VP-SEC) 014E/2024 May 9, 2024 Subject: Management's Discussion and Analysis of Operating Results for Q1-2024 To: The President of the Stock Exchange of Thailand Summary of Operations Q1-2024
-1- AIT (VP-SEC) 017E/2024 8 August 2024 Subject: Management's Discussion and Analysis of Operating Results for Q2-2024 To: The President of the Stock Exchange of Thailand Summary of Operations Q1
AIT (VP-SEC) 027E/2024 7 November 2024 Subject: Management’s Discussion and Analysis of Operating Results for Q3-2024 To: The President of the Stock Exchange of Thailand Summary of Operations Q3-2024